Short communication: High prevalence of vitamin D deficiency in HIV-infected and HIV-uninfected pregnant women
- PMID: 23675655
- PMCID: PMC3749690
- DOI: 10.1089/aid.2012.0384
Short communication: High prevalence of vitamin D deficiency in HIV-infected and HIV-uninfected pregnant women
Abstract
Vitamin D deficiency is common in HIV-infected populations. In resource-limited settings, vitamin D deficiency has been shown to affect HIV disease progression and mortality in pregnant women, and also increases mother-to-child HIV transmission and mortality in their infants. This study sought to investigate vitamin D status in HIV-infected women compared to healthy controls in a high-income country setting and determine variables associated with vitamin D deficiency. We prospectively enrolled 40 women/infant pairs (16 HIV-infected women/HIV-exposed infant pairs and 24 uninfected/unexposed pairs). In serum cord blood, 25-hydroxyvitamin D [25(OH)D] concentrations were suboptimal (<30 ng/ml) in 100% of subjects from both groups. White race, non-Hispanic ethnicity was the only variable associated with higher serum 25(OH)D concentrations. This high prevalence of vitamin D deficiency, especially among HIV-infected women and their infants, deserves further investigation, as it may have a negative impact on maternal and infant health.
References
-
- Brown TT. McComsey GA. Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther. 2010;15(3):425–429. - PubMed
-
- Viard JP. Souberbielle JC. Kirk O, et al. Vitamin D and clinical disease progression in HIV infection: Results from the EuroSIDA study. AIDS. 2011;25(10):1305–1315. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
